Quanterix To Present At Cowen And Company 36th Annual Health Care Conference
Lexington, Mass. – Quanterix Corporation, a leader in the transformation of healthcare through its ultrasensitive single molecule testing capabilities, announced that Kevin Hrusovsky, Executive Chairman and CEO, will present at the Cowen and Company 36th Annual Health Care Conference at the Boston Marriott Copley Place today at 5:30 p.m. ET in the MIT Room.
“Quanterix is in an increasingly strong position to create compelling value, not only for investors, but for the betterment of human health as a whole,” said Hrusovsky. “Our technology continues to demonstrate the game-changing capabilities it has for both life sciences and diagnostics.”
Hrusovsky will provide a corporate overview of Quanterix and his strategic vision for transforming healthcare. Quanterix is experiencing triple-digit growth and has received numerous industry awards and recognitions, including being named one of Fast Company’s Most Innovative Companies for 2016, and winning the prominent GE – NFL Head Health Challenge which funds innovative technologies that detect early stage mild traumatic brain injuries. With a strong pipeline of new research for 2016, Quanterix has already been featured in over 50 distinguished scientific publications.
A link to Kevin’s presentation can be found here: http://info.quanterix.com/watch-quanterix-jp-morganhealthcare-presentation.
Quanterix is a developer of ground-breaking tools in high definition diagnostics. Its Simoa platform uses single molecule measurements to access previously undetectable proteins. With this unprecedented sensitivity and full automation, Simoa offers significant benefits to both research and clinical testing applications. Quanterix was established in 2007 and is located in Lexington, Massachusetts. To learn more about Quanterix and Simoa, please visit: www.quanterix.com.
Nikki Festa & Caitlyn Keating
Share this page